Showing 1 - 8 results of 8 for search 'Nabil E Omar', query time: 0.03s
Refine Results
-
1
-
2
Tyrosine Kinase Inhibitors in pediatric chronic myeloid leukemia: a focused review of clinical trials by Fateen Ata, Maria Benkhadra, Rola Ghasoub, Liam J. Fernyhough, Nabil E. Omar, Nabil E. Omar, Abdulqadir J. Nashwan, Mahmood B. Aldapt, Kamran Mushtaq, Nancy A. Kassem, Mohamed A. Yassin
Published 2023-12-01
Article -
3
-
4
-
5
Tracheoesophageal fistula and esophageal perforation in a patient with advanced gastroesophageal junction tumor post ramucirumab treatment. A case report and literature review by Ahmed Abdalhadi, Mouhammad J Alawad, Nabil E. Omar, Muhammed Hajmusa, Mohammed Gaber, Alaaeldin Shablak
Published 2023-03-01
Article -
6
Early predictors of intensive care unit admission among COVID-19 patients in Qatar by Safae Abuyousef, Shaikha Alnaimi, Nabil E. Omar, Nabil E. Omar, Reem Elajez, Eman Elmekaty, Eiman Abdelfattah-Arafa, Raja Barazi, Rola Ghasoub, Ala Rahhal, Fatima Hamou, Maha Al-Amri, Ahmed Karawia, Fatima Ajaj, Raja Alkhawaja, Ahmed Kardousha, Ahmed Awaisu, Adel Abou-Ali, Mohamad Khatib, Mohammed Aboukamar, Moza Al-Hail
Published 2024-03-01
Article -
7
Real-World Data Presenting the Descriptive Analysis of the Use of Tyrosine Kinase Inhibitors (TKIs) Among Metastatic Non–Small-Cell Lung Cancer (mNSCLC) Patients in Qatar: A Nation... by Rawan Dawoud, Harman Saman, Kakil Rasul, Farah Jibril, Arwa Sahal, Randa Al-Okka, Yaser Mahfouz, Nabil E. Omar, Anas Hamad, Reyad Mohsen, Aladdin Kanbour, Naim Battikh, Prem Chandra, Shereen Elazzazy
Published 2024-10-01
Article -
8
Post‐COVID‐19‐associated multiorgan complications or “long COVID” with literature review and management strategy discussion: A meta‐analysis by Phool Iqbal, Fateen Ata, Hassan Chaudhry, Bassam Muthanna, Hafiz Waqas Younas, Syed Ata ul Munamm, Rohit Sharma, Kahtan Fadah, Shereen Elazzazy, Anas Hamad, Osama Said Abu Tabar, Nabil E. Omar
Published 2023-04-01
Article